These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1921016)

  • 1. [The progress pattern of carcinoma in situ of the urinary bladder].
    Okaneya T; Ikado S; Ogawa A
    Nihon Hinyokika Gakkai Zasshi; 1991 Aug; 82(8):1227-32. PubMed ID: 1921016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical study of carcinoma in situ of the urinary bladder].
    Harada Y; Seguchi T; Nonomura N; Kojima Y; Miki T; Okuyama A
    Nihon Hinyokika Gakkai Zasshi; 1998 Aug; 89(8):693-7. PubMed ID: 9780653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 2-week maintenance regimen of intravesical instillation of bacillus Calmette-Guerin is safe, adherent and effective in patients with non-muscle-invasive bladder cancer: a prospective, multicenter phase II clinical trial.
    Kanagawa Urological Research Group (KURG)
    Jpn J Clin Oncol; 2012 Sep; 42(9):813-9. PubMed ID: 22761255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effect of intravesical bacillus Calmette-Guerin on flat carcinoma in situ of the bladder.
    Herr HW; Pinsky CM; Whitmore WF; Sogani PC; Oettgen HF; Melamed MR
    J Urol; 1986 Feb; 135(2):265-7. PubMed ID: 3511284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stromal invasion of the prostate following a complete response to bacillus Calmette-Guerin instillation therapy for carcinoma in situ of the ureter and the bladder.
    Hara I; Yao A; Muramaki M; Hikosaka S; Yamada Y; Kawabata G; Kamidono S
    Int J Urol; 2004 Apr; 11(4):250-2. PubMed ID: 15028107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinoma in situ of the urinary bladder. Effect of associated neoplastic lesions on clinical course and treatment.
    Fukui I; Yokokawa M; Sekine H; Yamada T; Hosoda K; Ishiwata D; Oka K; Sarada T; Tohma T; Yamada T
    Cancer; 1987 Jan; 59(1):164-73. PubMed ID: 3791145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Results of adjuvant intravesical Bacillus Calmette-Guérin therapy for grade 3 superficial bladder cancer].
    Yumura Y; Oogo Y; Takase K; Hamano A; Yamashita Y; Noguchi S; Satomi Y
    Hinyokika Kiyo; 2004 Nov; 50(11):767-71. PubMed ID: 15628536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superficial bladder cancer treated with bacillus Calmette-Guerin: a multivariate analysis of factors affecting tumor progression.
    Herr HW; Badalament RA; Amato DA; Laudone VP; Fair WR; Whitmore WF
    J Urol; 1989 Jan; 141(1):22-9. PubMed ID: 2908949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing treatment response after induction Bacillus Calmette-Guerin for carcinoma in situ of the urinary bladder: can post-induction random bladder biopsies be avoided?
    Smith PJ; Lotan Y; Raj GV; Sagalowsky AI; Margulis V
    Cytopathology; 2014 Apr; 25(2):108-11. PubMed ID: 23551700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical assessment of carcinoma in situ of the human urinary bladder.
    Tsujihashi H; Nakanishi A; Matsuda H; Uejima S; Akiyama T; Kurita T
    Int Urol Nephrol; 1992; 24(3):243-54. PubMed ID: 1399381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased infiltration of tumor associated macrophages is associated with poor prognosis of bladder carcinoma in situ after intravesical bacillus Calmette-Guerin instillation.
    Takayama H; Nishimura K; Tsujimura A; Nakai Y; Nakayama M; Aozasa K; Okuyama A; Nonomura N
    J Urol; 2009 Apr; 181(4):1894-900. PubMed ID: 19237175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of early failures after intravesical instillation therapy with bacille Calmette-Guérin for carcinoma in situ of the bladder.
    Merz VW; Marth D; Kraft R; Ackermann DK; Zingg EJ; Studer UE
    Br J Urol; 1995 Feb; 75(2):180-4. PubMed ID: 7850322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term followup of patients treated with 1 or 2, 6-week courses of intravesical bacillus Calmette-Guerin: analysis of possible predictors of response free of tumor.
    Coplen DE; Marcus MD; Myers JA; Ratliff TL; Catalona WJ
    J Urol; 1990 Sep; 144(3):652-7. PubMed ID: 2388321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential Expression of PD-L1 in High Grade T1 vs Muscle Invasive Bladder Carcinoma and its Prognostic Implications.
    Wankowicz SAM; Werner L; Orsola A; Novak J; Bowden M; Choueiri TK; de Torres I; Morote J; Freeman GJ; Signoretti S; Bellmunt J
    J Urol; 2017 Oct; 198(4):817-823. PubMed ID: 28487100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urothelial Carcinoma In Situ of the Bladder With Glandular Differentiation: Report of 92 Cases.
    Yang Z; Epstein JI
    Am J Surg Pathol; 2018 Jul; 42(7):971-976. PubMed ID: 29683821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis of carcinoma in situ according to the presence of papillary bladder tumors after bacillus Calmette-Guérin immunotherapy.
    Kim SJ; You D; Jeong IG; Song C; Hong B; Kim CS; Ahn H; Hong JH
    J Cancer Res Clin Oncol; 2019 Aug; 145(8):2131-2140. PubMed ID: 31227894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of tumor-associated macrophages count in human non-muscle-invasive bladder cancer treated by BCG immunotherapy.
    Ajili F; Kourda N; Darouiche A; Chebil M; Boubaker S
    Ultrastruct Pathol; 2013 Feb; 37(1):56-61. PubMed ID: 23383616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinoma in situ of the urinary bladder. Clinical presentation, cytologic pattern and stromal changes.
    Boon ME; Blomjous CE; Zwartendijk J; Heinhuis RJ; Ooms EC
    Acta Cytol; 1986; 30(4):360-6. PubMed ID: 3461646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.
    Solsona E; Iborra I; Ricos JV; Monros JL; Rubio J; Almenar S
    J Urol; 2002 May; 167(5):2007-11. PubMed ID: 11956428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience with intravesical bacillus Calmette-Guèrin therapy of superficial bladder tumors.
    Herr HW; Pinsky CM; Whitmore WF; Sogani PG; Oettgen HF; Melamed MR
    Urology; 1985 Feb; 25(2):119-23. PubMed ID: 3881870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.